Ginkgo Bioworks Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins (July 19, 2023) | By BioSpace. ARLINGTON, Va. and BOSTON, July 19, 2023 /PRNewswire/ — Approved for Public Release, Distribution Unlimited — Defense Advanced Research Projects Agency (DARPA) announced that Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell
Continue ReadingDTx Pharma announces acquisition by Novartis (July 17, 2023) | By Christina Trout – DTx Pharma. DTx Pharma’s Fatty Acid Ligand Conjugated Oligonucleotide (FALCON™) platform facilitates extra-hepatic delivery of siRNA therapeutics Acquisition includes DTx-1252 with the potential to deliver a transformative medicine to Charcot-Marie-Tooth Disease Type 1A (CMT1A) patients Acquisition also includes additional early-stage programs in
Continue ReadingTakeda, F-star Sign Potential $1B Immuno-Oncology Agreement (July 7, 2023) | By Tristan Manalac. Takeda has entered into a strategic discovery collaboration and licensing agreement with British biotech F-star Therapeutics to develop next-generation and multi-specific antibodies for undisclosed cancer indications, the companies announced Wednesday. The partners did not reveal how much Takeda paid upfront
Continue Reading